share_log

DEFA14A: Others

DEFA14A: Others

DEFA14A:其他
美股SEC公告 ·  11/12 22:36

牛牛AI助手已提取核心信息

180 Life Sciences Corp. has announced the availability of proxy materials for its upcoming Annual Meeting of Stockholders scheduled for December 27, 2024. The meeting will be held online at 1:00 P.M. Pacific Time. Stockholders are encouraged to access and review the proxy materials available on the internet prior to voting. The agenda for the meeting includes the election of three Class II directors, the adoption of the third amendment to the company's charter, advisory resolutions on executive compensation, and approval of stock issuances for NASDAQ compliance. Additionally, the ratification of M&K CPAS, PLLC as independent auditors for the fiscal year ending December 31, 2024, will be addressed. The record date for stockholders entitled to vote has been set as October 31, 2024. The Board of Directors recommends voting 'for' all the proposals. Stockholders have until 11:59 PM Eastern Time on December 26, 2024, to submit their voting instructions online.
180 Life Sciences Corp. has announced the availability of proxy materials for its upcoming Annual Meeting of Stockholders scheduled for December 27, 2024. The meeting will be held online at 1:00 P.M. Pacific Time. Stockholders are encouraged to access and review the proxy materials available on the internet prior to voting. The agenda for the meeting includes the election of three Class II directors, the adoption of the third amendment to the company's charter, advisory resolutions on executive compensation, and approval of stock issuances for NASDAQ compliance. Additionally, the ratification of M&K CPAS, PLLC as independent auditors for the fiscal year ending December 31, 2024, will be addressed. The record date for stockholders entitled to vote has been set as October 31, 2024. The Board of Directors recommends voting 'for' all the proposals. Stockholders have until 11:59 PM Eastern Time on December 26, 2024, to submit their voting instructions online.
180生命科学公司宣布已经发布代理材料,用于即将于2024年12月27日举行的股东年度会议。会议将在线上于太平洋时间下午1:00举行。股东被鼓励在投票前访问并查看互联网上提供的代理材料。会议议程包括选举三位II类董事、通过公司宪章的第三次修正案、有关执行薪酬的咨询决议,以及批准用于纳斯达克合规的股票发行。此外,还将讨论批准M&k CPAS,PLLC作为独立审计师,负责截至2024年12月31日的财政年度。股东有资格投票的记录日期已确定为2024年10月31日。董事会建议投票“赞成”所有提案。股东需在2024年12月26日东部时间晚上11:59前在线提交投票指示。
180生命科学公司宣布已经发布代理材料,用于即将于2024年12月27日举行的股东年度会议。会议将在线上于太平洋时间下午1:00举行。股东被鼓励在投票前访问并查看互联网上提供的代理材料。会议议程包括选举三位II类董事、通过公司宪章的第三次修正案、有关执行薪酬的咨询决议,以及批准用于纳斯达克合规的股票发行。此外,还将讨论批准M&k CPAS,PLLC作为独立审计师,负责截至2024年12月31日的财政年度。股东有资格投票的记录日期已确定为2024年10月31日。董事会建议投票“赞成”所有提案。股东需在2024年12月26日东部时间晚上11:59前在线提交投票指示。

译文内容由第三方软件翻译。


牛牛AI助手部分由第三方人工智能模型基于资讯内容自动生成,只对中国内地以外的地区提供。


以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。